KMD Bioscience Co., Ltd.
400-621-6806
Service Line：+1-315-239-3085
Address：FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
| Catalog Number | YR1541 |
|---|---|
| Product Name | Anti-Human APP Recombinant Antibody(Donanemab) |
| Molecular Name | Donanemab |
| Alias | Anti-APP Recombinant Antibody, Research Grade Donanemab |
| CAS Number | 1931944-80-7 |
| Target | APP[Homo sapiens] |
| Isotype | IgG1 Kappa |
| Clonity | Monoclonal |
| Source | CHO Cells |
| Size | 1mg, 5mg |
| Concentration | 1mg/ml |
| Purity | >95% as determined by SDS-PAGE |
| Buffer | PBS, pH7.5 |
| Background | Donanemab (USAN, development code LY3002813) is a biological drug in trial to treat early symptoms of Alzheimer's disease. There is no cure or treatment for Alzheimer’s disease. Donanemab has shown positive results in Eli Lilly and Co.’s first two trials. |
| Storage | It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles. |
| Note | This product is for research use only. |
FL-4, Building A5, International Enterprise Community, Tianjin, China
Email：[email protected]
Hot Line： +1-315-239-3085
Technical Support：[email protected]
